![]() |
|
|
U.S. Department of Agriculture/Agriculture Research Service, Childrens Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030
3To whom correspondence should be addressed. E-mail: tdavis{at}bcm.tmc.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: neonate insulin signaling protein synthesis muscle growth
The insulin signaling cascade is initiated by insulin on binding to its receptor (1). This leads to activation of the insulin receptor tyrosine kinase and subsequent phosphorylation of several cytosolic substrates, primarily the insulin receptor substrate (IRS)3 proteins (2,3). IRS proteins function as "docking proteins," transmitting insulin signals to several proteins that contain Src-homology 2 (SH2) domains (4), including phosphatidylinositol (PI) 3-kinase, which triggers the downstream signaling pathway to insulin-stimulated biological responses such as glucose and amino acid transport, glycogen synthesis and protein synthesis (5).
Several studies indicate that early steps of the insulin signaling pathway play an important role in the regulation of protein synthesis (68). Our in vivo studies in neonatal pigs suggest that the feeding-induced stimulation of skeletal muscle protein synthesis can be completely reproduced by the infusion of insulin, even when glucose and amino acids are maintained at fasting levels (9,10). This response to insulin decreases with development, in parallel with the developmental decline in the response to feeding (11). This suggests that the developmental decline in the response to feeding reflects a change in insulin-mediated signals that stimulate translation initiation (1214).
Our recent studies in muscle of suckling pigs showed that there is a developmental decrease in insulin receptor (IR) activation, which is paralleled by the developmental decrease in muscle protein synthesis (13). The enhanced insulin receptor activation in skeletal muscle of 7- compared with 26-d-old pigs is due in part to a higher receptor number and to enhanced tyrosine phosphorylation of the insulin receptor. This developmental decline in insulin receptor activation is transduced to downstream signaling components including IRS-1, PI 3-kinase, protein kinase B, 70-kDa ribosomal protein S6 kinase and the eukaryotic initiation factor repressor protein, 4E-BPI (12,14). Furthermore, the higher IR activation in muscle of the neonate is associated with reduced activity of protein tyrosine phosphatase-1B (PTP-1B), which functions to dephosphorylate the activated IR (15). Nonetheless, the signaling components that regulate the enhanced activation of the insulin receptor in skeletal muscle of the neonate are not completely known.
In muscle and other tissues that express both IR and insulin-like growth factor-I receptor (IGF-IR), hybrid receptors, composed of an insulin receptor
ß-heterodimer and an IGF-I receptor
ß-heterodimer, can be formed (16,17). Although the molecular mechanism of hybrid receptor formation is not known, functional analysis indicates that insulin/IGF-I hybrid receptors function more like IGF-I receptors with respect to a higher affinity to IGF-I than to insulin and to receptor autophosphorylation (18,19). For that reason, an increased proportion of hybrid receptors will reduce insulin binding, resulting in compromised insulin sensitivity in tissues expressing both receptors (20). Indeed, enhanced hybrid receptor abundance has been reported in insulin-resistant states (2022). In the current study, we tested the hypothesis that in muscle of suckling pigs, insulin/IGF-I hybrid receptor abundance and binding affinity increase with development, consistent with our previous report (13) on the developmental decline in the activation of the insulin signaling pathway.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Crossbred (Landrace x Yorkshire x Duroc x Hampshire) pregnant sows (Agriculture Headquarters, Texas Department of Criminal Justice, Huntsville, TX) were housed in lactation crates in individual, environmentally controlled rooms 2 wk before farrowing. Sows (n = 2) were fed a commercial diet (5084, PMI Feeds, Richmond, IN) and had free access to water. After farrowing, piglets remained with the sow and were not given supplemental creep feed. Piglets were studied at 7 and 26 d of age; body weight (2.62 ± 0.12 and 9.71 ± 0.77 kg, respectively) was similar to that of artificially raised piglets (23). Four piglets were used in each age group. Pigs were fed after overnight food deprivation via two gavage administrations of 30 mL/kg body weight of porcine mature milk (University of Nebraska, Lincoln, NE) at 60-min intervals. Pigs were killed 30 min after they were last fed; samples of longissimus dorsi muscle and liver were rinsed in ice-cold saline and rapidly frozen. The protocol was approved by the Animal Care and Use Committee of Baylor College of Medicine and was conducted in accordance with the NRC guidelines (24).
Materials.
BioMag goat anti-mouse IgG and goat anti-rabbit IgG magnetic beads were obtained from Polysciences (Warrington, PA), and the magnetic sample rack was from Promega (Madison, WI). Reagents for SDS-PAGE were from Bio-Rad Laboratories (Richmond, CA). The protein assay kit was purchased from Pierce (Rockford, IL). Anti-human insulin receptor antibody (SC-711) and anti-human IGF-I receptor antibody (SC-9038) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The enhanced chemiluminescence Western blotting detection kit (ECL-Plus) was obtained from Amersham (Arlington Heights, IL). 125I-insulin and 125I-IGF-1 were purchased from Amersham Biosciences (Piscataway, NJ). Other chemicals and reagents were from Sigma Chemical (St. Louis, MO).
Preparation of tissue extracts.
Samples for immunoblotting were prepared by a previously described method (13). Briefly, samples of frozen muscle were pulverized in liquid nitrogen and homogenized in ice-cold homogenization buffer. The homogenate was incubated for 45 min at 4°C with gentle mixing and then centrifuged at 35,000 x g for 1 h at 4°C. The supernatant was collected and an aliquot was assayed for protein concentration using the bicinchoninic acid assay (Pierce).
Immunoprecipitation.
To determine IR, IGF-I and IR/IGF-I hybrid receptor abundance, protein samples from tissue extract preparations were immunoprecipitated with anti-IR or anti-IGF-IR antibody. The immunoprecipitation procedure was conducted according to Suryawan et al. (13). Briefly, equal amounts of protein (500 µg protein in 500 µL buffer) were incubated by gentle rocking overnight at 4°C with 20 µL of primary antibody (IR or IGF-IR antibody). The next day, 500 µL of secondary antibody (goat anti-rabbit IgG linked to magnetic beads) was added. After 1 h incubation at 4°C, the samples were washed three times in low salt buffer using a magnetic sample rack, and resuspended in 500 µL of low salt buffer containing 10 g/L dry skim milk. Each sample was added to 500 µL of resuspended beads and rocked for at least 1 h at 4°C. The beads were captured using the magnetic rack and washed twice in low salt buffer and once in high salt buffer. The captured beads were resuspended in 100 µL 1X sample buffer, boiled for 5 min and stored at -80°C until electrophoresis.
Western blot analysis.
To measure IR or IGF-IR abundance, equal amounts of IR and IGF-IR immunoprecipitant were subjected to SDS-PAGE (13). The proteins were then transferred to a polyvinylidene difluoride membrane using transfer buffer overnight. The membrane was incubated for 1 h at room temperature in a Tris-buffered saline-Tween 20 solution containing 50 g/L nonfat dried milk. After the blocking step, the membrane was incubated with anti-human IR or IGF-IR antibodies for 1 h followed by incubation with secondary antibody. After several washings, the membranes were developed with an enhanced chemiluminescence detection kit (ECL-Plus, Amersham Pharmacia) before exposure onto Kodak-X-Omat film. The blots were quantified by computerized densitometry (Molecular Dynamics). To measure the hybrid receptor abundance, an equal amount of IR immunoprecipitant was subjected to SDS-PAGE followed by immunoblotting as above, using IGF-I antibody as the primary antibody.
The ligand binding affinity assay.
The binding assay was used according to Federici et al. (20). Microwells (96-well) were coated with 50 µL of anti-IR or anti-IGF-I antibody (both 10 mg/L) by incubation for 16 h at 4°C, then washed three times with binding buffer A containing 50 mmol/L Hepes buffer, pH 7.6, 150 mmol/L NaCl, 1 mL/L Triton X-100, 1g/L bacitracin, 2 mmol/L phenylmethylsulfonyl fluoride, 106 U/L aprotinin and 1 g/L bovine serum albumin. For analysis of insulin binding affinity to its receptor, IGF-I binding affinity to its receptor and IGF-I binding affinity to hybrid receptor, 500-µg tissue samples were extracted and equal amounts of protein were incubated in anti-IR, anti- IGF-I or anti-IGF-I-coated wells in buffer A containing 125I-insulin (60 pmol/L) or 125I-IGF-1 (60 pmol/L) for 16 h at 4°C in the presence or absence of unlabeled insulin or unlabeled IGF-I, respectively. After washing with buffer A to remove the unbound ligand, radioactivity bound to immobilized receptors was collected by adding 20 g/L SDS for 30 min at 24°C and was counted in a gamma counter. Insulin and IGF-I binding data were analyzed by a sigmoidal dose-response model using the PRISM computer program (GraphPad Software, San Diego, CA).
Statistics.
ANOVA (general linear modeling) was used to assess the effect of development. Differences with P-values < 0.05 were considered significant. Animals were the experimental unit. Data are means ± SEM.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Because the insulin/IGF-I hybrid receptor abundance is tightly related to IR and IGF-IR abundance, we first determined IR and IGF-IR abundance. IR abundance and IGF-IR abundance were
75 and >50% higher, respectively, in skeletal muscle of 7- than in 26-d-old pigs. The current studies are consistent with other studies showing that insulin receptor abundance in muscle is higher in suckling than in adult rats and dogs (26,27). However, in those studies, unlike the current study, age-related changes in IR abundance were compounded by changes in diet composition. Furthermore, in pig skeletal muscle, IGF-IR mRNA levels decrease with advancing age (28).
Accumulated evidence indicates that there are important differences in function between IR and IGF-IR, i.e., the IR appears to be a vital mediator of metabolic responses, whereas IGF-IR is involved primarily in the control of growth, development and differentiation (29). Moreover, despite genetic evidence showing that IGF-IR is generally a growth promoter, whereas IR is a metabolic regulator (30), recent in vivo studies indicate that IGF-I can function like insulin as well, i.e., IGF-I stimulates glucose transport in human skeletal muscle (31), and IGF-I infusion can reproduce the insulin-induced stimulation of skeletal muscle protein synthesis in suckling pigs (32). Hence, our results indicate that the enhanced IR and/or IGF-IR abundance in suckling muscle may contribute to the higher growth rate of skeletal muscle during early postnatal development.
To examine other factors that may influence insulin sensitivity in muscle of suckling pigs, we determined the abundance and proportion of insulin/IGF-I hybrid receptors. The results indicate that the insulin/IGF-I hybrid receptor abundance is nearly two-fold higher in muscle of 7- than in 26-d-old pigs. However, the relative proportion of hybrid receptors to both IR and IGF-IR was similar at both ages. To the best of our knowledge, this is the first study to examine the developmental changes in the abundance and relative proportion of insulin/IGF-I hybrid receptors. Accumulated evidence indicates that the hybrid receptor in muscle of obese and type 2 diabetic individuals is positively correlated with insulin resistance (22,33). Therefore, the lack of developmental changes in hybrid receptor abundance relative to IR and IGF-IR abundance in skeletal muscle of the neonate indicates that other mechanisms may be responsible for the insulin hypersensitivity of the neonate. Because the response of muscle protein synthesis to insulin decreases profoundly between 7 and 26 d of age (9), these results further suggest that insulin/IGF-I hybrid receptors do not play an important role in modulating the developmental changes in the insulin responsiveness of muscle protein synthesis in the neonate.
Because we did not observe differences between the age groups in the relative proportion of hybrid receptors to IR and IGF-IR and because insulin sensitivity is affected by insulin receptor binding affinity as well as receptor number (34), we determined insulin and IGF-I binding affinities to their receptors and IGF-I binding affinity to the hybrid receptor. Receptor binding affinity, estimated as the concentration of unlabeled insulin or IGF-I required to inhibit 50% of maximum 125I-insulin or 125I-IGF-I binding to immobilized insulin, IGF-I and insulin/IGF-I hybrid receptors (EC50), did not differ at the two ages. Similar findings, that insulin and IGF-I binding affinities to their receptors are unaffected by development, were reported in studies involving rats (26). However, to the best of our knowledge, this study was the first to examine the effect of development on IGF-I binding affinity to hybrid receptor. From these results, we conclude that the insulin receptor number, but not the insulin receptor or hybrid receptor binding affinities, likely contributes to the enhanced insulin sensitivity in muscle of suckling pigs.
We showed previously that insulin receptor activation, as measured by ß-IR phosphorylation per IR abundance, is higher in muscle of 7- than in 26-d-old pigs (13). Thus, the enhanced insulin sensitivity in muscle of 7-d-old pigs was not due solely to the elevated IR abundance, but to other regulators as well. Recently, we found that the activity of PTP-1B, a phosphotyrosine phosphatase that attenuates insulin signaling by catalyzing the dephosphorylation of the insulin receptor, increases with development (15). This suggests that the reduced PTP-1B activation in muscle of suckling pigs also contributes to the enhanced insulin sensitivity of skeletal muscle in young pigs.
In conclusion, the current study tested the hypothesis that insulin/IGF-I hybrid receptor abundance and binding affinity increase with development, consistent with the developmental decline in the activation of the insulin signaling pathway. However, the data do not support our hypothesis, but instead show that hybrid receptor abundance decreases with development. Moreover, when expressed in relative proportion to IR or IGF-I-R, hybrid receptor abundance does not change with development. Hybrid receptor binding affinity also does not change with development. This suggests that insulin/IGF-I hybrid receptors do not contribute to the enhanced insulin sensitivity of skeletal muscle in suckling pigs and implies that other factors play a crucial role in the regulation of insulin receptor activation. Because a better understanding of the molecular mechanisms that regulate the activation of signal transduction pathways that modulate insulin-stimulated muscle protein synthesis is important to the development of improved strategies to promote animal growth, further search for these unknown factors is warranted.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Funded in part by National Institute of Arthritis and Musculoskeletal and Skin Diseases Institute Grant R01-AR-44474 (T.A.D.) and USDA/ARS CRIS 6250510000-033 (T.A.D.). ![]()
4 Abbreviations used: IGF-I, insulin-like growth factor-1; IGF-IR, insulin-like growth factor-1 receptor; IR, insulin receptor; IRS, insulin receptor substrate; PI 3-kinase, phosphatidylinositol 3-kinase; PTP-1B, protein tyrosine phosphatase-1B; SH2, Src-homology 2. ![]()
Manuscript received 22 January 2003. Initial review completed 16 April 2003. Revision accepted 20 June 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. White, M. F. & Kahn, C. R. (1994) The insulin-signaling system. J. Biol. Chem. 269:1-4.
2. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Cahill, P. A., Goldstein, B. J. & White, M. F. (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (Lond.) 352:73-77.[Medline]
3. Sun, X. J., Wang, L. M., Zhang, Y., Yenush, L., Myers, M. G., Glasheen, E., Lane, W. S., Pierce, J. H. & White, M. F. (1995) Role of IRS-2 in insulin and cytokine signaling. Nature (Lond.) 377:173-177.[Medline]
4. Solow, B. T., Harada, S., Goldstein, B. J., Smith, J. A., White, M. F. & Jarett, L. (1999) Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor substrate) proteins. Mol. Endocrinol. 13:1784-1798.
5. Egawa, K., Sharma, P. M., Nakashima, N., Huang, Y., Huver, E., Boss, G. R. & Olefsky, J. M. (1999) Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J. Biol. Chem. 274:14306-14314.
6. Sun, X. J., Crimmins, D. L., Myers, M. G., Miralpeix, M. & White, M. F. (1993) Pleiotrophic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13:7418-7428.
7. Yamauchi, T., Tobe, K., Tamemoro, H., Ueki, K., Kaburagi, Y., Yamamoto-Honda, R., Takahashi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., Soneberg, N., Yazaki, Y. & Kadowaki, T. (1996) Insulin-signaling and insulin action in muscles and livers of insulin-resistant, insulin substrate 1-deficient mice. Mol. Cell. Biol. 16:3074-3084.[Abstract]
8. Mendez, R., Myers, M. G., White, M. F. & Rhoads, R. E. (1996) Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-1 phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 16:2857-2864.[Abstract]
9. Wray-Cahen, D., Nguyen, H. V., Burrin, D. G., Beckett, P. R., Fiorotto, M. L., Reeds, P. J., Wester, T. J. & Davis, T. A. (1998) Response of skeletal muscle protein synthesis to insulin in suckling pigs decreases with development. Am. J. Physiol. 275:E602-E609.
10. Davis, T. A., Fiorotto, M. L., Beckett, P. R., Burrin, D. G., Reeds, P. J., Wray-Cahen, D. & Nguyen, H. V. (2001) Differential effects of insulin on peripheral and visceral tissue protein synthesis in neonatal pigs. Am. J. Physiol. 280:E770-E779.
11. Davis, T. A., Burrin, D. G., Fiorotto, M. L. & Nguyen, H. V. (1996) Protein synthesis in skeletal muscle and jejunum is more responsive to feeding in 7- than in 26-d-old pigs. Am. J. Physiol. 270:E802-E809.
12. Davis, T. A., Nguyen, H. V., Suryawan, A., Bush, J. A., Jefferson, L. S. & Kimball, S. R. (2000) Developmental changes in the feeding-induced stimulation of translation initiation in skeletal muscle and liver of neonatal pigs. Am. J. Physiol. 279:E1226-E1234.
13. Suryawan, A., Nguyen, H. V., Bush, J. A. & Davis, T. A. (2001) Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs. Am. J. Physiol. 281:E908-E915.
14. Kimball, S. R., Farrell, P. A., Nguyen, H. V., Jefferson, L. S. & Davis, T. A. (2002) Developmental decline in components of signal transduction pathways regulating protein synthesis in pig muscle. Am. J. Physiol. 282:E585-E592.
15. Suryawan, A. & Davis, T. A. (2002) Protein tyrosine phosphatase 1B activation is developmentally regulated in muscle of neonatal pigs. Am. J. Physiol. 284:E47-E54.
16. Soos, M. A. & Siddle, K. (1989) Immunological relationships between receptors for insulin and insulin-like growth factor I.Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem. J. 263:553-563.[Medline]
17. Moxham, C. P., Duronio, V. & Jacobs, S. (1989) Insulin-like growth factor I receptor beta-subunit heterogeneity.Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J. Biol. Chem. 264:13238-13244.
18. Frattali, A. L. & Pessin, J. E. (1993) Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-I hybrid receptors. J. Biol. Chem. 268:7393-7400.
19. Seely, B. L., Reichart, D. R., Takata, Y., Yip, C. C. & Olefsky, J. M. (1995) A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology 136:1635-1641.[Abstract]
20. Federici, M., Zucaro, L., Porzio, O., Massoud, R., Borboni, P., Lauro, D. & Sesti, G. (1996) Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects. J. Clin. Investig. 98:2887-2893.[Medline]
21. Frattali, A. L., Treadway, J. L. & Pessin, J. E. (1992) Insulin/IGF-1 hybrid receptors: implications for the dominant-negative phenotype in syndromes of insulin resistance. J. Cell. Biochem. 48:43-50.[Medline]
22. Simpson, H. L., Umpleby, A. M. & Russell-Jones, D. L. (1998) Insulin-like growth factor-I and diabetes. Growth Horm. IGF Res. 8:83-95.[Medline]
23. Oliver, W. T., Touchette, K. J., Coalson, J. A., Whisnant, C. S., Brown, J. A., Mathews, S. A., Odle, J. & Harrell, R. J. ((2003)) Pigs weaned from the sow at 10 d of age respond to dietary energy source of manufactured liquid diets and exogenous porcine somatotropin (pST). J. Anim. Sci. (in press).
24. National Research Council (1996) Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, DC.
25. Combettes-Souverain, M. & Issad, T. (1998) Molecular basis of insulin action. Diabetes Metab. 24:477-489.[Medline]
26. Alexandrides, T., Moses, A. C. & Smith, R. J. (1989) Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology 124:1064-1076.[Abstract]
27. Johnston, V., Frazzini, V., Davidheiser, S., Przybylski, R. J. & Kliegman, R. M. (1991) Insulin receptor number and binding affinity in newborn dogs. Pediatr. Res. 29:611-614.[Medline]
28. Peng, M., Pelletier, G., Palin, M. F., Veronneau, S., LeBel, D. & Abribat, T. (1996) Ontogeny of IGFs and IGFBPs mRNA levels and tissue concentrations in liver, kidney and skeletal muscle of pig. Growth Dev. Aging 60:171-187.[Medline]
29. Dupont, J. & LeRoith, D. (2001) Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm. Res. 55:22-26.
30. Kim, J. J. & Accili, D. (2002) Signalling through IGF-I and insulin receptors: where is the specificity?. Growth Horm. IGF Res. 12:84-90.[Medline]
31. Dohm, G. L., Elton, C. W., Raju, M. S., Mooney, N. D., DiMarchi, R., Pories, W. J., Flickinger, E. G., Atkinson, S. M. & Jr & Caro, J. F. (1990) IGF-Istimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes 39:1028-1032.[Abstract]
32. Davis, T. A., Fiorotto, M. L., Burrin, D. G., Vann, R. C., Reeds, P. J., Nguyen, H. V., Beckett, P. R. & Bush, J. A. (2002) Acute IGF-I infusion stimulates protein synthesis in skeletal muscle and other tissues of neonatal pigs. Am. J. Physiol. 283:E638-E647.
33. Federici, M., Porzio, O., Lauro, D., Borboni, P., Giovannone, B., Zucaro, L., Hribal, M. L. & Sesti, G. (1998) Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. J. Clin. Endocrinol. Metab. 83:2911-2915.
34. Kahn, C. R. (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893-1902.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||